1. Home
  2. STELLA PHARMA NEWS
STELLA PHARMA NEWS
Press Release BNCT
March 4th, 2024

Interim Analysis Results of Post-Marketing Surveillance of Our Drug Product published ― Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer

The results regarding safety and effectiveness of our product Borofalan(10B), u……

READ MORE

Press Release BNCT
January 11th, 2024

Investigator-initiated Phase I BNCT clinical trial for newly diagnosed glioblastoma

We would like to announce that Phase I clinical trial for newly diagnosed gliob……

READ MORE

BNCT SPM-011 Information
December 25th, 2023

Orphan Drug designation for Borofalan (10B) (SPM-011) as treatment of Cutaneous Angiosarcoma

Angiosarcoma is a kind of cancer that is derived from vascular endothelial cell……

READ MORE

Press Release BNCT
December 13th, 2023

Stella Pharma, Mitsubishi Chemical Group, and the University of Tokyo conclude Joint Research Agreement—Accelerating practical application of polyvinyl alcohol (PVA) for boron neutron capture therapy (BNCT)—

Stella Pharma Corporation , Mitsubishi Chemical Corporation of the Mitsubishi C……

READ MORE

BNCT Information
December 6th, 2023

Encounter with Director of Cancer Research Center of Lyon, and Team of Centre Léon Bérard at French Embassy

Business France Japan Office of the French Embassy in Japan engages in building……

READ MORE

Information
September 29th, 2022

Groundbreaking Ceremony for the Hainan BNCT Center

On 25th September, the Groundbreaking Ceremony for the Boao BNCT center has tak……

READ MORE

Information
September 27th, 2022

Stella Pharma Presented at Side Events of the 66th IAEA General Conference

The 66th International Atomic Energy Agency (IAEA) General Conference is being ……

READ MORE

Press Release BNCT
June 24th, 2022

Notice Regarding Our First Overseas Introduction of BNCT in the Hainan Medical Tourism Pilot Zone, China

Sumitomo Heavy Industries, Ltd. and STELLA PHARMA CORPORATION have respectively……

READ MORE

Information
April 7th, 2022

Stella Pharma Corporation was nominated as a finalist of the Informa Pharma Intelligence Awards Japan 2022

Informa Pharma Intelligence has announced that Stella Pharma is a nominee f……

READ MORE

BNCT Information
February 18th, 2022

“Destroying Cancer with Boron and Neutrons” will be on NHK WORLD-JAPAN

Japan's public media organization NHK (Japan Broadcasting Corporation) will bro……

READ MORE

BNCT Information
October 21st, 2021

Interview published on Science Japan, online magazine| Japan’s “Fifth Cancer Treatment,” BNCT, Finally Off the Ground

Here is a featured story on BNCT (Boron Neutron Capture Therapy) boron drug dev……

READ MORE

BNCT Information
June 23rd, 2021

The phase II study of recurrent glioblastoma in Japan has published in “Neuro-Oncology Advances”

The title is “Accelerator-based BNCT for patients with recurrent glioblastoma: ……

READ MORE

←1234